Tales of Transformation

Delve into the world of cell and gene therapies, where precision medicine meets complex supply chains and high-risk production. In this episode, industry experts discuss the challenges and opportunities arising from cell and gene manufacturing—and how organizations can better navigate the multi-stakeholder landscape by utilizing digital technologies. Tune in for insights to help you reshape the future of personalized medicine.

This episode of Tales of Transformation examines how artificial intelligence is a key next step in the evolution of life sciences and healthcare companies towards the future of health.

This episode of Tales of Transformation examines health equity and ways the health care ecosystem is working together to address social, economic, and environmental drivers

This episode of Tales of Transformation explores the renewed focus on the global behavioral health crisis in response to the pandemic and how digital engagement and partnerships can improve outcomes.

This episode of Tales of transformation explores the future of health spending and its dramatic transformation driven by new business models, emerging technologies, and engaged customers

This episode of Tales of transformation explores the impact that health tech innovation has had on traditional health care incumbents and its role in the future of health post-pandemic.

How can life sciences organizations start shifting away from today’s silos to reach the connected future of health?

Hear what health care organizations are already doing to improve connectivity and some of the biggest challenges that could prevent the industry from achieving radical interoperability.

Tune in to hear why organizations should use upcoming regulations as a jumping off point to develop and implement a strategic interoperability plan.

How will radically interoperable data increase collaboration across the health care ecosystem? And what does “radical interoperability” actually mean? Tune in to find out.

Tune in as we explore how health care organizations can integrate risk into their strategic decisions and take advantage of opportunities in the future of health.

While the future of health does introduce new risks, opportunities abound for organizations who can get in front of these risks and make smart changes to their business models.

Connected data will play a huge role in the future of health—and will bring new opportunities to life sciences and health care organizations. But what risks will they need to be on the lookout for?

Tune in as we kick off season four to explore how your life sciences and health care organization can stay ahead of emerging risks in the industry.

Consumer engagement in life sciences and health care continues to grow, from searching for care and accessing new channels of care to tracking and sharing health data and using new digital tools and technologies. How could this increased engagement spill over to the regulatory environment? Or will it?

The life sciences sector already operates in one of the most regulated industries in the world. The pace of technological advancement, including the emergence of new digital health products, is adding to this complexity, and in some cases, leading to some uncertainty regarding regulators’ expectations and requirements. How will industry regulations evolve to address emerging technologies and digital capabilities?

Digital Technologies are disrupting organizations of every size and shape, leaving many executives scrambling to find and assess the new technologies that will help their organizations compete now and in the future. Life science companies are no exception. However, while the technology itself is vital to digital transformation, the importance of strong leadership and culture cannot be overlooked. What roles do leadership and culture play in helping life sciences organizations move from simply doing digital to being digital?

New technologies and digital transformation offer biopharmaceutical and medtech companies opportunities across their organizations—from how they conduct research and interact with regulators to how they optimize their finance, supply chains, and manufacturing operations. New digital capabilities can also change the game in how companies engage with their customers, patients, and other stakeholders. However, life sciences companies have not traditionally been early adopters of new technologies. What is holding life sciences companies back? How can they better take advantage of new digital capabilities? And how do they demonstrate impact and ROI from their investments?

The final episode of season two explores the topic of “radical interoperability” and how players across the life sciences and health care industry can work together to create a more connected ecosystem.

This episode explores the biggest trends and technologies disrupting life sciences and health care and driving the industry toward a radically different future.